MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Gilead Sciences (NASDAQ: GILD) | Delayed: 157.19 +3.62 (2.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $153.57 | 52 Week High | $108.63 | |||
| Open | $154.24 | 52 Week Low | $71.39 | |||
| Day High | $157.42 | P/E | 86.85 | |||
| Day Low | $153.00 | EPS | $1.81 | |||
| Volume | 6,210,466 | |||||
| MACROGENICS (NASDAQ: MGNX) | Delayed: 3.63 +0.04 (1.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.59 | 52 Week High | $36.11 | |||
| Open | $3.59 | 52 Week Low | $14.84 | |||
| Day High | $3.67 | P/E | 9.31 | |||
| Day Low | $3.52 | EPS | $0.39 | |||
| Volume | 465,521 | |||||
